Country for PR: China
Contributor: PR Newswire Asia (China)
Wednesday, April 29 2020 - 10:00
AsiaNet
SEASUN BIOMATERIALS to launch COVID-19 Rapid Molecular Assay
SEOUL, South Korea, Apr. 29, 2020 /PRNewswire-AsiaNet/--

SEASUN BIOMATERIALS announced on 1 May that they are about to release their 
second COVID-19 assay "AQ-TOP COVID-19 Rapid Detection Kit" just after the 
completion of FDA EUA (April-27) of their U-TOP COVID-19 Real-Time Detection 
Kit. 

Analytical Speed, Sensitivity and Specificity of the conventional molecular 
methods were enhanced with AQ-TOP technology through the combination of 
isothermal amplification and PNA (Peptide Nucleic Acid) detection probe, which 
has high accurate binding efficiency to the target nucleic acid.

This kit targets ORF1ab gene of SARS-CoV-2 with an endogenous control human 
RNase P gene. The kit obtained CE-IVD marking in March, and now examinations of 
an export approval of MFDS (Korea's Ministry of Food & Drug Safety) and the FDA 
EUA are underway.

CEO Hee-Kyung Park said, "Customers don't need to purchase an additional 
equipment. The existing real-time PCR instrument which is frequently used for 
COVID-19 diagnosis can be used as it is. The average number of specimens that 
can be tested per unit (12 hours per day) is 3,400, which is 5-6 times faster 
than before. Currently, as COVID-19 is rapidly spreading globally and 
re-infection is reported frequently, we will produce more than 200,000 tests 
per day to deliver as fast as possible. As soon as the permit for the AQ-TOP 
COVID-19 Rapid Detection Kit has been completed, the kit will be provided 
globally and with the advantage that the rapid COVID-19 diagnosis will 
contribute to quick follow-up."

SEASUN BIOMATERIALS is currently distributing its real-time PCR based "U-TOP 
COVID-19 Detection Kit" which acquired CE-IVD marking, Certificate of Free 
Sales of MFDS (in February) and the FDA-EUA (on April-27), to overseas 
including Europe and the Middle Eastern countries. 

About SEASUN BIOMATERIALS

SEASUN BIOMATERIALS is an in vitro diagnostic company that develops molecular 
diagnostic platforms of infection diseases, cancer as well as genetic and 
epigenetic disorders.

We develop and commercialize innovative real-time PCR-based diagnostic 
platforms through the development of our proprietary technologies to provide 
more advanced molecular diagnostic services.  

www.seasunbio.com 

Source: SEASUN BIOMATERIALS

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=362646

   Caption: SEASUN BIOMATERIALS, AQ-TOP COVID-19 rapid detection Kit

Attachments
PR83799.jpg
Translations

Japanese

Vietnamese